Day 2, Wednesday, March 19th, 2025 - EST/EDT (Eastern Daylight, GMT-4)
- Patrick Gomez Menzies - Head of Market Access, AIR, US, Chiesi USA, Inc.
Provide a comprehensive understanding of the existing regulatory landscape governing patient support services and hub models, including FDA guidelines, compliance standards and industry best practices
Gain valuable insights into the latest enforcement actions and the ramifications of recent cases
Uncover the top areas of focus for 2025
- Omar Richardson - Senior Director of Compliance, Shionogi Inc.
- David Walk - Deputy Chief, Criminal Division, U.S. Attorney's Office, District of New Jersey
- David Blank - Former Senior Counsel, HHS/OIG, Partner, Arnall Golden Gregory LLP
After hearing from Enforcement directly, take this opportunity for a broader level set. Gain insight into current policies and pending changes to understand how the patient services industry will continue to be affected and what your organization can do to prepare and adapt accordingly.
- Jennie Sakimura - Senior Director, Patient Services & Specialty Pharmacy Programs, Sanofi
- Michael Kolber - Partner, Manatt, Phelps & Phillips, LLP
In a continually complex and evolving marketplace, brands need innovative ways to support patients and providers, but they also need to think about how changes will impact the future of hub services as we know them today. This session explores evolving strategies for creative collaboration with innovators and downstream partners with an emphasis on fulfilling the promise of technology with a holistic approach to patient services.
- Learn how new technology ecosystems enable plug-and-play capabilities with a wide network of dynamic partnerships outside your traditional hub support vendors
- Increasing visibility to each step of the patient journey
- Discuss technology strategies that effectively streamline operational efficiencies, provide more engaging data insights, and mitigate program risk
- Improve operating models by adeptly orchestrating people and processes to realize the promise and potential of technology
- Myra Reinhardt - Vice President, Customer Solutions, Cencora
- Andrew Denzin - Vice President, Client Strategy and Support, Cencora
As patient adherence continues to evolve alongside the rest of the patient services industry, take look at the new adherence design stands and benchmarking.
- Understand the importance of tailoring access & adherence programs to individual patient needs, preferences and conditions
- Learn how to use patient reported outcomes to measure access, adherence and effectiveness to inform program adjustments
- Incorporating digital health tools, including AI, ML and beyond, to improve access & adherence in combination with live support in rare diseases
- Steve Fields - Vice President, Patient Access & Reimbursement, Inizio Engage
- Meghan Petit - Patient Access Solution Consultant, Inizio Engage
- Robert Sexton - Head, Commercial Strategy, Insights, & Analytics, Legend Biotech
- Megan Guhl - Executive Director, Head of Patient Access Services, Incyte Corporation
This panel discussion presents real-life case studies showcasing the evolving role of automation in healthcare and its synergy with nursing collaboration to improve patient outcome.
- Learn strategies from industry experts on improving operational efficiency and empowering nurses to facilitate prior authorization, patient adherence and comprehensive care
- Gain valuable insights into best practices for blending automation with human-centered support to create a seamless patient experience and optimize healthcare resources
- Blake Johnson - Vice President, Business Development, Mercalis
- Angela Aksdal - Director, Patient Services, Immunology & Neurology, Sandoz
- Heather Smith - Vice President, Clinical Operations, Mercalis
The industry has aligned on standard playbooks for program structure, but a select few companies yield differentiated results. Do they follow the playbook better than others, or do they make different strategic and tactical investments? Learn how innovative executives are structuring their programs for better visibility, measurement and agility to deliver an enhanced patient experience and differentiated program results.
- Danny Sigurdson - CEO, Courier Health
- Heath Nivens - Vice President, Patient Access Solutions, Lundbeck
- Deb Reardon - Vice President, Patient Excellence, Boehringer Ingelheim
- Megan Guhl - Executive Director, Head of Patient Access Services, Incyte Corporation
Conversations are a source of insight that can be a powerful unifying force leveraged to align on strategy, problem-solving, intelligence and service. In this panel, we’ll discuss how AI is being utilized to understand the context of the healthcare experience at every stage of the brand lifecycle, delivering value for both business and patient outcomes.
- Hear from your peers how conversational data provides value at every stage of the brand lifecycle, from launch, steady state, competition and to patent expiration
- Learn about common friction points in the patient journey and how teams are navigating and generating solutions by listening at scale
- Identify actionable ways artificial intelligence can help you achieve the outcomes for your business and for the patients you serve
- Jenna Phillips - Director, Life Sciences Sales, Authenticx
- Geoff Fisher - Director, Specialty & Oncology Patient Assistance Programs, GSK
- Deb Reardon - Vice President, Patient Excellence, Boehringer Ingelheim
- April Onufrak - Associated Director of Digital Solutions, Lilly Patient Services
Though the Inflation Reduction Act is well under way, stakeholders must remain agile. During this session, understand the impact that the IRA has had thus far on patient services and how it is going to continue to evolve.
Receive an update on how the IRA is going and the specific changes that organizations are seeing
Benchmark with peers to understand how their patient services have shifted as a result
Understand the updated Medicare out-of-pocket cap and what it means for manufacturers as they think about affordability
- Joel White - President, Horizon Government Affairs
- Fauzea Hussain - Vice President, Public Policy, McKesson
While integrated specialty pharmacy services are not new, they are becoming a more popular model of care as the number of complex care treatments on the market continues to increase.
Learn more about the technologies and systems that medically integrated specialty pharmacies (MIPs) use to improve efficiency and patient outcome
Uncover the benefits MIPs provide for healthcare practices, patients and costs by allowing for real-time access to patient medical records, labs and notes and easier access to prescribing clinicians
Learn how MIPs allow for more holistic and focused patient support
- Karen Thomas - Associate Director, Specialty and Infusion Pharmacies and Clinical Assistant Professor, University of Illinois Chicago
- Joshua Weber - Director, Specialty & Home Delivery Pharmacy Services, UVA Health Pharmacy
With retail pharmacy, specialty pharmacies, specialty distributors and more, there is a whole distribution model playbook that manufacturers must consider when launching a new product.
Uncover the challenges in retail pharmacy, including over saturation
Discuss alternative options to retail pharmacies and their respective considerations
Understand the benefit of patient services working with trade and distribution to maximize value and minimize cost
- Meghan Hover, MBA - Executive Director, Patient Services and Trade, SK Life Science
- Chris Boneham - Vice President, Market Access US, Y-mAbs Therapeutics, Inc